Wilbanks Smith & Thomas Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,036
| Closed | -$500K | – | 523 |
|
|
2022
Q3 | $500K | Hold |
2,036
| – | – | 0.02% | 287 |
|
|
2022
Q2 | $504K | Sell |
2,036
-3
| -0.1% | -$743 | 0.02% | 296 |
|
|
2022
Q1 | $583K | Buy |
2,039
+3
| +0.1% | +$858 | 0.02% | 284 |
|
|
2021
Q4 | $731K | Hold |
2,036
| – | – | 0.03% | 275 |
|
|
2021
Q3 | $663K | Hold |
2,036
| – | – | 0.03% | 268 |
|
|
2021
Q2 | $635K | Hold |
2,036
| – | – | 0.02% | 276 |
|
|
2021
Q1 | $649K | Hold |
2,036
| – | – | 0.03% | 257 |
|
|
2020
Q4 | $660K | Hold |
2,036
| – | – | 0.03% | 231 |
|
|
2020
Q3 | $564K | Hold |
2,036
| – | – | 0.03% | 228 |
|
|
2020
Q2 | $492K | Hold |
2,036
| – | – | 0.03% | 238 |
|
|
2020
Q1 | $296K | Hold |
2,036
| – | – | 0.02% | 284 |
|
|
2019
Q4 | $347K | Hold |
2,036
| – | – | 0.02% | 308 |
|
|
2019
Q3 | $362K | Sell |
2,036
-25
| -1% | -$4.45K | 0.02% | 277 |
|
|
2019
Q2 | $537K | Sell |
2,061
-5
| -0.2% | -$1.3K | 0.03% | 223 |
|
|
2019
Q1 | $590K | Sell |
2,066
-10
| -0.5% | -$2.86K | 0.04% | 218 |
|
|
2018
Q4 | $675K | Hold |
2,076
| – | – | 0.05% | 177 |
|
|
2018
Q3 | $934K | Sell |
2,076
-2
| -0.1% | -$900 | 0.06% | 175 |
|
|
2018
Q2 | $850K | Sell |
2,078
-294
| -12% | -$120K | 0.07% | 146 |
|
|
2018
Q1 | $690K | Sell |
2,372
-85
| -3% | -$24.7K | 0.06% | 163 |
|
|
2017
Q4 | $460K | Buy |
2,457
+161
| +7% | +$30.1K | 0.04% | 206 |
|
|
2017
Q3 | $387K | Hold |
2,296
| – | – | 0.03% | 219 |
|
|
2017
Q2 | $329K | Hold |
2,296
| – | – | 0.03% | 224 |
|
|
2017
Q1 | $287K | Hold |
2,296
| – | – | 0.02% | 243 |
|
|
2016
Q4 | $259K | Sell |
2,296
-5
| -0.2% | -$564 | 0.02% | 250 |
|
|
2016
Q3 | $296K | Sell |
2,301
-7
| -0.3% | -$900 | 0.03% | 221 |
|
|
2016
Q2 | $252K | Hold |
2,308
| – | – | 0.03% | 244 |
|
|
2016
Q1 | $219K | Buy |
2,308
+2
| +0.1% | +$190 | 0.03% | 258 |
|
|
2015
Q4 | $208K | Buy |
2,306
+10
| +0.4% | +$902 | 0.02% | 253 |
|
|
2015
Q3 | $213K | Buy |
+2,296
| New | +$213K | 0.03% | 245 |
|